Cong Si Tran, Julia Kersten, Jingyi Yan, Marco Breinig, Thorben Huth, Tanja Poth, Ombretta Colasanti, Tobias Riedl, Suzanne Faure-Dupuy, Stefan Diehl, Lieven Verhoye, Teng-Feng Li, Marit Lingemann, Philipp Schult, Gustaf Ahlén, Lars Frelin, Florian Kühnel, Florian W R Vondran, Kai Breuhahn, Philip Meuleman, Mathias Heikenwälder, Peter Schirmacher, Ralf Bartenschlager, Vibor Laketa, Stephanie Roessler, Darjus Felix Tschaharganeh, Matti Sällberg, Volker Lohmann
BACKGROUND AND AIMS: High expression of phosphatidylinositol 4-kinase III alpha (PI4KIIIα) correlates with poor survival rates in patients with hepatocellular carcinoma (HCC). In addition, Hepatitis C virus (HCV) infections activate PI4KIIIα and contribute to HCC progression. We aimed at mechanistically understanding the impact of PI4KIIIα on the progression of liver cancer and the potential contribution of HCV in this process. METHODS: Several hepatic cell culture and mouse models were used to study functional importance of PI4KIIIα on liver pathogenesis...
April 16, 2024: Gastroenterology